A Blood Peptide That Reveals Hidden Liver Scarring in Alcoholic Liver Disease
A peptide fragment from collagen production correlates strongly with liver scarring severity, potentially offering a blood test alternative to liver biopsy.
Quick Facts
What This Study Found
Serum amino-terminal type III procollagen peptide levels showed a strong positive correlation with the degree of liver fibrosis (r = 0.733, p < 0.001) in patients with alcoholic liver disease. In contrast, serum proline levels and standard liver function tests failed to correlate significantly with the actual extent of fibrotic tissue measured by morphometric analysis of liver biopsies.
Key Numbers
r = 0.733, p < 0.001
How They Did This
Cross-sectional study comparing serum proline and amino-terminal type III procollagen peptide levels against liver biopsy morphometric analysis in 31 patients with alcoholic liver disease and 15 healthy controls.
Why This Research Matters
Detecting liver fibrosis early in alcoholic liver disease is critical for preventing progression to cirrhosis. Standard blood tests often miss fibrosis. This study identified a peptide biomarker — amino-terminal type III procollagen peptide — that tracks closely with the actual amount of scar tissue in the liver, offering a potential non-invasive way to monitor disease severity.
The Bigger Picture
This 1986 study was an early demonstration that peptide biomarkers could detect organ damage that standard tests miss. The concept of using collagen-derived peptide fragments as fibrosis markers has since expanded into a broader field of non-invasive fibrosis diagnostics, influencing the development of modern scoring systems like FibroTest and ELF panels.
What This Study Doesn't Tell Us
Small sample size of 31 patients limits generalizability. The cross-sectional design cannot establish whether peptide levels change over time with disease progression. The study is from 1986 and newer fibrosis markers have since been developed.
Questions This Raises
- ?How does this peptide biomarker compare to modern non-invasive fibrosis scores developed since this study?
- ?Can serial measurements of procollagen peptide levels track fibrosis regression after alcohol cessation?
- ?Does this biomarker perform similarly in non-alcoholic liver fibrosis?
Trust & Context
- Key Stat:
- r = 0.733 Correlation between blood procollagen peptide levels and actual liver fibrosis area measured by biopsy
- Evidence Grade:
- This is a small cross-sectional study with 46 participants. The strong correlation is notable but the sample size is limited and the study design cannot prove causation.
- Study Age:
- Published in 1986, this is a foundational study in peptide-based fibrosis diagnostics. Its core concept has been validated and expanded by decades of subsequent research.
- Original Title:
- Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
- Published In:
- Digestive diseases and sciences, 31(7), 712-7 (1986)
- Authors:
- Tanaka, Y, Minato, Y, Hasumura, Y, Takeuchi, J
- Database ID:
- RPEP-00038
Evidence Hierarchy
Frequently Asked Questions
What is amino-terminal type III procollagen peptide?
It's a small peptide fragment released into the blood when the body produces type III collagen — a process that increases when the liver is forming scar tissue. Measuring this peptide can reveal hidden fibrosis.
Can this blood test replace a liver biopsy?
Not entirely, but it offers a non-invasive indicator of fibrosis severity. Since 1986, this concept has evolved into modern fibrosis scoring panels that reduce the need for biopsies in many patients.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00038APA
Tanaka, Y; Minato, Y; Hasumura, Y; Takeuchi, J. (1986). Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.. Digestive diseases and sciences, 31(7), 712-7.
MLA
Tanaka, Y, et al. "Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.." Digestive diseases and sciences, 1986.
RethinkPeptides
RethinkPeptides Research Database. "Evaluation of hepatic fibrosis by serum proline and amino-te..." RPEP-00038. Retrieved from https://rethinkpeptides.com/research/tanaka-1986-evaluation-of-hepatic-fibrosis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.